Trisomy 13

12 registered clinical trials studyying Trisomy 13.

Status	Trial	Sponsor	Phase
Completed	Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies NCT05004337	Natera, Inc.	—
Unknown	Study of Vanadis® NIPT for Non-invasive Prenatal Screening of Trisomies (T21, T18 and T13) NCT03559374	PerkinElmer, Wallac Oy	—
Completed	VAlidation of a Lower Cost aneUploidy scrEen NCT03087357	Women and Infants Hospital of Rhode Island	—
Completed	SNP-based Microdeletion and Aneuploidy RegisTry (SMART) NCT02381457	Natera, Inc.	—
Completed	High Risk Multiple Gestation Study NCT02278874	Natera, Inc.	—
Completed	Prenatal Screening for Down Syndrome With DNAFirst NCT01966991	Women and Infants Hospital of Rhode Island	—
Completed	Non-Invasive Chromosomal Evaluation of Trisomy Study NCT02201862	Cindy Cisneros	—
Completed	Study of the Efficacy of New Non-invasive Prenatal Tests for Screening for Fetal Trisomies Using Maternal Bloo NCT01925742	CHU de Quebec-Universite Laval	N/A
Completed	Multiple Gestation Study NCT02278536	Natera, Inc.	—
Completed	Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Matern NCT01852708	Natera, Inc.	—
Completed	Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA NCT02109770	Natera, Inc.	—
Terminated	Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial NCT01545674	Natera, Inc.	—